Childrens Xyzal Allergy
NDC 41167-3533, Levocetirizine dihydrochloride, solution, from Chattem, Inc..
- Product NDC
- 41167-3533
- Status
- Listed
- Labeler
- Chattem, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA209090
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/41167-3533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE2.5 mg/5mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 41167-3533-0 | 41167353300 | 1 BOTTLE in 1 CARTON (41167-3533-0) / 148 mL in 1 BOTTLE |
| 41167-3533-1 | 41167353301 | 1 BOTTLE in 1 CARTON (41167-3533-1) / 295 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 41167-3533 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/41167-3533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 41167-3533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.